During the Congress in Prague, 2019, the Research Network was launched under the inspiring leadership of Said Laribi, the immediate past-chair of EUSEM Research Committee.
Why
The research network will allow:
- Building large scale descriptive data on Emergency Medicine in Europe
- Developing common research methodology among participating countries
- Improve knowledge in EM through international comparisons
- Improve EUSEM visibility among scientific societies.
Aims
- Perform descriptive EM research projects in Europe
- Perform clinical trials related to Emergency Medicine
- Establish partnerships with other international EM networks with the aim of developing global research
- Carry out scientific research training regarding Emergency Medicine
- Promote student and researcher exchange
- Apply for European research grants.
How
- Each country affiliated to EUSEM will have one country lead identified in the EUSEM Research Network
- Country lead will be the contact for his/her country with the Research network chair and the EUSEM office
Country lead
- Will be in charge of recruiting and coordinating EM sites in his/her country
- Will be in charge of all ethical and regulatory procedures regarding research projects in his/her country
Local site PI
- Will be in charge of all ethical and regulatory procedures regarding the research projects in his/her hospital.
- Recruit patients on a voluntary basis.
- Fill in the anonymized electronic Case Report Form (CRF).
- Local PI will be included in a study group in all publications using their data
Research Network chair
- Will coordinate all activities of the research network, in collaboration with country leads, the Research committee and the EUSEM office
- Help building research projects with the research committee members
- Build the electronic case report form with the help of the EUSEM office
- Coordinate the publication plan of the different projects in collaboration with the research project PI.
Achievements:
- EUROCOV study (2020, PI S Laribi, France
- EGERS study (2020, PI M Karamercan, Turkey)
- SEED study (2022, PI M Reed, UK)
